Severity of obstructive sleep apnea and extension of coronary artery disease

Silveria J Rivera-Pérez1, Denis Martinez1,2, Gustavo N Araujo3,4

  • 1School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Insights

Obstructive sleep apnea (OSA) is linked to coronary artery disease (CAD), but this study found no direct dose-response relationship between OSA severity and CAD severity. Moderate-to-severe OSA predicts the presence of CAD, not its extent.

Area of Science:

  • Cardiology
  • Sleep Medicine
  • Pulmonology

Background:

  • Obstructive sleep apnea (OSA) is common in patients with coronary artery disease (CAD).
  • The correlation between OSA severity and CAD severity remains unclear.
  • Investigating this link is crucial for understanding cardiovascular disease pathogenesis.

Purpose of the Study:

  • To explore the relationship between the apnea-hypopnea index (AHI) and the Gensini score in patients with suspected CAD.
  • To determine if a dose-response relationship exists between OSA severity and CAD severity.
  • To assess the association between moderate-to-severe OSA and the presence of CAD.

Main Methods:

  • A cross-sectional study involving 80 patients undergoing cardiac catheterization for suspected CAD.
  • Apnea-hypopnea index (AHI) determined via polysomnography for OSA severity.
  • Gensini score used to quantify the extent and severity of coronary artery lesions.

Main Results:

  • No significant correlation was found between AHI and Gensini score (r=0.08, rho=0.13).
  • Moderate-to-severe OSA (AHI ≥ 15) predicted the presence of CAD (Gensini score ≥ 2) with a large effect size (OR 4.46).
  • Clinical characteristics were similar between CAD cases and non-CAD controls.

Conclusions:

  • Moderate-to-severe OSA is associated with the presence of CAD.
  • No significant correlation exists between OSA severity (AHI) and CAD severity (Gensini score).
  • OSA likely influences CAD pathogenesis, but a direct dose-response relationship is improbable.
Abstract

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
555
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
443
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
372
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
687